1. Can low-molecular-weight heparin improve the outcome of patients with operable non-small cell lung cancer? An urgent call for research;Alifano;Chest,2004
2. Are low molecular weight heparins the same?;Mousa;Methods Mol Med,2004
3. Anti-angiogenic mechanisms and efficacy of the low molecular weight heparin, tinzaparin: anti-cancer efficacy;Mousa;Oncol Rep,2004
4. Antimetastatic effect of tinzaparin, a low-molecular-weight heparin;Amirkhosravi;J Thromb Haemost,2003
5. Actions of heparin that may affect the malignant process;Engelberg;Cancer,1999